Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eliot Morrison

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecular Therapy. Nucleic Acids|October 11, 2024
The beauty of symmetry: siRNA phosphorodithioate modifications reduce stereocomplexity, ease analysis, and can improve <i>in vivo</i> potencySophie Schöllkopf, Stefan Rathjen, Micaela Graglia, et al.
Genome Biology|July 31, 2020
Splicing-accessible coding 3'UTRs control protein stability and interaction networksMarco Preussner, Qingsong Gao, Eliot Morrison, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2020
Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of <i>HLA-DOA</i> That Have Altered FunctionAustin M Graves, Francesca Virdis, Eliot Morrison, et al.
Communications Biology|July 12, 2020
Dynamic palmitoylation events following T-cell receptor signalingEliot Morrison, Tatjana Wegner, Andres Ernesto Zucchetti, et al.
Atherosclerosis|April 11, 2022
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular diseaseDavid A Rider, Mona Eisermann, Kathrin Löffler, et al.
European Journal of Microbiology & Immunology|July 11, 2017
The Guanine-Nucleotide Exchange Factor Caldag Gefi Fine-Tunes Functional Properties of Regulatory T CellsJana Niemz, Stefanie Kliche, Marina C Pils, et al.
Nucleic Acid Therapeutics|February 6, 2025
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry RecommendationsPatrik Andersson, Sebastien A Burel, Heather Estrella, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular Therapy. Nucleic Acids|October 11, 2024
The beauty of symmetry: siRNA phosphorodithioate modifications reduce stereocomplexity, ease analysis, and can improve <i>in vivo</i> potencySophie Schöllkopf, Stefan Rathjen, Micaela Graglia, et al.
Genome Biology|July 31, 2020
Splicing-accessible coding 3'UTRs control protein stability and interaction networksMarco Preussner, Qingsong Gao, Eliot Morrison, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2020
Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of <i>HLA-DOA</i> That Have Altered FunctionAustin M Graves, Francesca Virdis, Eliot Morrison, et al.
Communications Biology|July 12, 2020
Dynamic palmitoylation events following T-cell receptor signalingEliot Morrison, Tatjana Wegner, Andres Ernesto Zucchetti, et al.
Atherosclerosis|April 11, 2022
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular diseaseDavid A Rider, Mona Eisermann, Kathrin Löffler, et al.
European Journal of Microbiology & Immunology|July 11, 2017
The Guanine-Nucleotide Exchange Factor Caldag Gefi Fine-Tunes Functional Properties of Regulatory T CellsJana Niemz, Stefanie Kliche, Marina C Pils, et al.
Nucleic Acid Therapeutics|February 6, 2025
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry RecommendationsPatrik Andersson, Sebastien A Burel, Heather Estrella, et al.
Pageof 2